CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-18 | Lenk Robert P Director | Grant or award · Stock Option (Right to Buy) | +40,122 | 40,122 | ||
| 2025-02-18 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +40,122 | 40,122 | ||
| 2025-02-18 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +400,489 | 400,489 | ||
| 2025-02-18 | Petersen Greg Director | Grant or award · Stock Option (Right to Buy) | +40,122 | 40,122 | ||
| 2025-02-18 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,020 | 60,020 | ||
| 2024-09-13 | Hawkins Richard J Director | Purchase | +4,000 | $1.50 | $6K | 15,188 |
| 2024-09-12 | Hawkins Richard J Director | Purchase | +6,285 | $1.35 | $9K | 11,188 |
| 2024-09-11 | Petersen Greg Director | Purchase | +12,500 | $1.35 | $17K | 48,921 |
| 2024-09-11 | Clowes Howard Director | Purchase | +5,000 | $1.34 | $7K | 26,497 |
| 2024-09-11 | Lenk Robert P Director | Grant or award · Stock Option (Right to Buy) | +3,650 | 3,650 | ||
| 2024-09-11 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +3,650 | 3,650 | ||
| 2024-09-11 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +3,650 | 3,650 | ||
| 2024-09-11 | Clowes Howard Director | Grant or award · Stock Option (Right to Buy) | +3,650 | 3,650 | ||
| 2024-09-11 | Petersen Greg Director | Grant or award · Stock Option (Right to Buy) | +3,650 | 3,650 | ||
| 2024-09-11 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +46,074 | 46,074 | ||
| 2024-09-11 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +197,595 | 197,595 | ||
| 2024-09-10 | HEDRICK MARC H Chief Executive Officer | Purchase | +8,000 | $1.23 | $10K | 20,425 |
| 2024-09-10 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +4,098 | $1.27 | $5K | 9,815 |
| 2024-05-08 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +4,902 | $2.04 | $10K | 5,717 |
| 2024-05-08 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Warrants (Right to buy) | +9,804 | 9,804 |
Page 6 of 53 · 1,048 trades